CD160 and tuberculosis: Consistent with established TB research in whole blood or PBMCs (28, 29, 51), our findings demonstrated distinct upregulated expression patterns of multiple IRs, including LAG-3, CD39, CD160, and VISTA, in active TB patients compared to TBI and HC individuals.